key: cord-0030895-1ufwbv9b authors: Chen, Wenqing; Li, Chen; Liang, Wanmin; Li, Yunqi; Zou, Zhuoheng; Xie, Yunxuan; Liao, Yangzeng; Yu, Lin; Lin, Qianyi; Huang, Meiying; Li, Zesong; Zhu, Xiao title: The Roles of Optogenetics and Technology in Neurobiology: A Review date: 2022-04-19 journal: Front Aging Neurosci DOI: 10.3389/fnagi.2022.867863 sha: b1349f3ac94fbd7e596eab138f4bedefb21b24c3 doc_id: 30895 cord_uid: 1ufwbv9b Optogenetic is a technique that combines optics and genetics to control specific neurons. This technique usually uses adenoviruses that encode photosensitive protein. The adenovirus may concentrate in a specific neural region. By shining light on the target nerve region, the photosensitive protein encoded by the adenovirus is controlled. Photosensitive proteins controlled by light can selectively allow ions inside and outside the cell membrane to pass through, resulting in inhibition or activation effects. Due to the high precision and minimally invasive, optogenetics has achieved good results in many fields, especially in the field of neuron functions and neural circuits. Significant advances have also been made in the study of many clinical diseases. This review focuses on the research of optogenetics in the field of neurobiology. These include how to use optogenetics to control nerve cells, study neural circuits, and treat diseases by changing the state of neurons. We hoped that this review will give a comprehensive understanding of the progress of optogenetics in the field of neurobiology. In 2005, optogenetics was born and appeared in the public (Boyden et al., 2005) . Since the advent of optogenetics, many top medical journals have described it as a core technology for the future of humanity (Method of the year, 2010; News, 2010; Adamantidis et al., 2015) . Optogenetics can be combined with molecular biology, viral biology and other methods to introduce foreign light-sensitive protein genes into living cells (Amitrano et al., 2021; Di Ventura and Weber, 2021) . Therefore, optogenetics has made many achievements in the field of neurobiology. Such as exploring unknown neuron functions (Figure 1) , the discovery of neural circuits (Figure 2) , and treatment of neurological diseases (Figure 3) . By using the technology of optogenetics, the research of many difficult diseases has been advanced greatly. Using optogenetics to induce the differentiation of neural progenitor cells, the researchers were able to treat stroke in mice (Yu et al., 2019; Peters et al., 2021; Vassalli et al., 2021) . The mice were able to remove and reactivate a memory by changing the connections between related neurons in the brain with different frequencies of light (Nabavi et al., 2014) . Blindness can be treated by using optogenetics to activate the photogene expression of the related photoactivation channels or pumps in retinal cells (Ostrovsky and Kirpichnikov, 2019) . This technology have led us into a higher research field. In 2019, Luo et al. (2019) used photoelectric fullerene-bound photosensitive protein (HEBR) to reprogram and differentiate human fibroblasts. In this study, researchers transfected HEBR plastids into human fibroblasts using fullerene as a cell culture substrate (Figure 1) . Previous research has shown that environmental stresses, such as acidity, can stimulate cell reprogramming. When the researchers illuminated HERB transfected fibroblasts with green light, the pH in and out of the transfected fibroblasts changed momentously, causing the fibroblasts to differentiate into neuron-like cells. This study has clinical significance in nerve repair. In other studies, researchers combined a variety of technologies, such as optogenetics, synthetic biology (Padmanabhan et al., 2019; Hemmati et al., 2020; Yi et al., 2020; Zhang et al., 2020) , for the first time to achieve far red light to control the expression of genomic genes. The far-red light-regulated CRISPR-dCas9 endogenous gene transcription activation device was developed for the first time (Gjaltema and Schulz, 2018) , which successfully induced the pluripotent stem cells into functional neural cells (Shao et al., 2018) . By combining BphS, which respond to red light proteins in rhodobacter, transcription factors BldD in streptococcus, and protein dCas9 in streptococcus pyogenes, this device can accurately realize the reversible activation of target genes inside and outside the organism, with high precision. Meanwhile, the frequency of light used in the study is in the physiological range and has no side effects on organisms. In theory, the results of this research can be widely used for precise epigenetic regulation (Hori and Kikuchi, 2019) . And, in the future, this technology may be applied in the clinical field to treat diseases such as muscular dystrophy (Vajtay et al., 2019) . In earlier studies, optogenetics simply stimulated neurons (Nowak et al., 2010) . Early applications of optogenetic control neurons were mainly two: driving proton pumps with light to charge mitochondria (Hallett et al., 2016) , and polarizing or depolarizing neurons (Yao et al., 2012) . By making a single neuron hyperpolarized, the function of this neuron can be studied (Aquili et al., 2014) . In the latest study, researchers can decode and control signaling pathways in neurons (Figure 1 ; Melero-Fernandez de Mera et al., 2017) . In this study, the intracellular signaling pathways of the organism can be controlled by light, using the main bioresonance effect of the organism. Using light to control specific signaling pathways that regulate the behavior of nerve cells, researchers can learn which neurons are involved in those pathways. In related studies, we can learn more about the JNK signaling pathway by inhibiting p38MAPK with OptoJNKI (a photosensitive substance that inhibits p38MAPK) (Melero-Fernandez de Mera et al., 2017) . Moreira et al. (2019) managed to control the taste of fruit flies by shining different LEDs on different taste neurons. In this study, the researchers managed to alter feeding behavior in fruit flies by manipulating taste receptors. This technique can be used to study the progression of clinical diseases and to discover new therapies. Studies have shown that people with schizophrenia and other psychiatric and neurological disorders have gamma oscillations in their brains (Gao et al., 2021a,b) . But exactly how gamma oscillations are produced is not clear Lu W. et al., 2020; Song et al., 2020) . Cardin et al. (2009) discovered how the brain produces gamma oscillations by using optogenetics to manipulate the activity of nerve cells. By manipulating the interneurons' related behavior with different frequencies of light, the researchers were able to observe the extent of the gamma oscillations produced by the interneurons. The research will contribute to a range of neurological disorders. In 2014, researchers used optogenetics to inactivate cells in parts of the rat brain (Figure 1 ) to identify the neurons responsible for behavioral decision-making (Aquili et al., 2014) . This study is the first to show that optogenetics inhibition of nucleus accumbens neurons during reward and false feedback can increase the behavioral complexity of individuals (Aquili et al., 2014) . In the same year, another researcher used optogenetics to identify neurons that control aggression in the hypothalamus of mice (Lee et al., 2014) . In 2017, scientists used optogenetics to find neurons in the brains of mice that control hunting behavior (Han et al., 2017) . Because the hypothalamus in humans and mice is structurally similar, these findings are also useful for studying human behavior. The Neural Circuits That Regulate Sodium Appetite Sodium ions are important ions in the nervous system that regulate neurons. If sodium ion is not ingested for a long time, it will cause symptoms such as loss of appetite, weakness of limbs and dizziness. When a variety of animals are deficient in sodium ions, they will consume a large amount of salt rich in sodium ions, which is called sodium appetite (Thornton and Fitzsimons, 1995; Geerling and Loewy, 2008; Molnar and Labouesse, 2021) . After a large intake of salt, the body will produce a sense of satisfaction to prevent further intake (Wolf et al., 1984) . Previous studies on sodium appetite were flawed and did not conform to the single variable principle of the experiment. Until 2019, Lee et al. (2019) demonstrated that the pre-LCPDYN neurons are the core neurons in the regulation of sodium appetite by combining optogenetics with other techniques, and are regulated by the homeostatic and sense-related brain regions (Table 1 and Figure 2 ). In this study, researchers used optogenetic techniques to inhibit pre-LCPDYN neurons, and found that the pre-LCPDYN neurons are essential in the neural circuits that regulate sodium appetite. This experiment has revealed the mechanism of nerve circuits regulating sodium appetite and related conclusions. 2 | The study of neural circuits by optogenetic methods. By targeting specific areas with light, specific neural circuits can be inhibited or activated, leading to behavioral changes in mice, and related neural circuits can be studied. Globally, obesity (Hosseinpanah et al., 2019; Lu D. et al., 2020) and type 2 diabetes (Broder et al., 2014; Song et al., 2020; are among the major diseases that endanger human health. Bad eating habits can bring about many diseases. Clinically, the treatment for severely obese patients is usually gastric bypass surgery. This approach is extremely traumatic. Optogenetics separates normal eating behavior from rewardseeking eating (Cardi et al., 2018) , providing new ideas for the treatment of this disease. Nieh et al. (2015) demonstrated that the hypothalamicventral tegmental pathway is involved in controlling feeding in FIGURE 3 | To study the mechanisms of clinical diseases using optogenetics. We can introduce photosensitive proteins outside the body, or we can introduce viruses that transmit photosensitive genes, or we can shine light directly on specific areas. This can lead to changes in cell membrane pathways in the irradiated area, which can affect cell function. The related functions of organisms can be altered to study clinical diseases. starving mice by activating or inhibiting specific neurons using optogenetics (Jennings et al., 2015 ; Table 1 and Figure 2 ). In this study, the researchers introduced light-sensitive proteins that control the activity of neurons into the lateral hypothalamiventral tegmental region (VTA) and activated the region with light, causing already satiated mice to take longer to eat. In another study, Sternson et al. successfully distinguished appetitive behavior (Sternson and Atasoy, 2014) from neurons that satisfy behavior (Atasoy et al., 2012; Gatto and Goulding, 2018) . In the study, the mice were given food freely or a reward for completing a task. Neuronal activity in the lateral hypothalamus of mice was also imaged. Based on this study, researchers were able to identify the neural basis of compulsive eating. In 2021, the researchers used an AVV virus vector to deliver the ChR2 light-sensitive protein gene to a specific vagus nerve in the stomach ; Table 1 and Figure 2 ). By using a tiny LED was inserted into the end of a flexible shaft in the stomach. Mice were successfully induced to feel full by external stimulation of specific gastric vagus nerve with remote radio frequency source. In 2022, researchers used optogenetics to inhibit neuropod cells in mice intestinal mucosa and found that mice consumed less sucrose (Buchanan et al., 2022) . These studies suggest that optogenetics has a role to play in understanding the neural circuit of compulsive feeding. Social behavior is one of the characteristics of biology, but the social behavior neural circuits of biology is hardly understood. But through optogenetics, scientists are unraveling the mysteries of biological social behavior. Chiang and his colleagues developed an automatic laser tracking and optogenetic manipulation system (Hsiao et al., 1408; Wu et al., 2014) (ALTOMS) that can be used to study the social memory of fruit flies. After the expression of photosensitive proteins in neurons at specific sites, neurons involved in pain expression photosensitive pathways can be activated when laser irradiation is applied to specific sites (Karim et al., 2006 ; Table 1 and Figure 2 ). Using the system, the researchers were able to get certain males to quickly learn to avoid females, while other males continued to approach. At the same time, automated laser tracking and optogenetic manipulation systems (ALTOMS) (Hsiao et al., 1408; Wu et al., 2014) are expected to help identify the neural circuits responsible for specific drosophila behavior and understand the circuitry behind the ability to form memories based on social interaction learning. In the latest study, researchers implanted tiny wireless optogenetic electronic devices into the brains of mice. The synchrony between brain neurons in the medial prefrontal cortex of mice induced social preference in mice ; Table 1 and Figure 2) . The micro technique used in this study was less invasive and had less effect on the natural behavior of mice. Now, optogenetics not only controls the behavior of rodents but also primates (Rajalingham et al., 2021) . These studies demonstrates the broad application of optogenetics in human social behavior circuits. Thermoregulation is important for many life activities (Davison, 1976) . Human beings have known for the last century that the thermoregulatory center is located in the hypothalamus (Hamilton and Ciaccia, 1971) , but it is difficult to use traditional methods to analyze the thermoregulatory mechanism. In order to elucidate the neurons and neural circuits of hypothalamus involved in body temperature regulation, relevant researchers used optogenetics combined with physiological calcium signal recording (Tretyn, 1999) and other means to conduct experiments from the level of neural circuits on the hypothalamus of mice (Zhao et al., 2017) . This study found neurons in the preoptic region of the hypothalamus that regulate thermally driven cooling behavior, as well as neurons in the dorsolateral part of the dorsolateral part of the hypothalamus responsible for the thermogenesis mechanism caused by cold stimulation. By using optogenetics to activate vLPO neurons, the researchers found that vLPO neurons are at the core neuron in thermoregulatory neural circuit (Table 1 and Figure 2 ; Zhao et al., 2017) . In addition, a new marker for heatsensitive neurons, brain-derived neurotrophic factor (BDNF), was identified (Ciszowski et al., 2016) . This study provides new clues for physiological and pathological research based on thermoregulation. Using techniques such as optogenetics, single synapse tracing (Spreafico et al., 1981) and in vivo multi-channel electrophysiological recording (Brozoski et al., 2006) , the researchers found that the excitatory pyramidal cells of the entorhinal cortex (ECIIPN) (Shu et al., 2016) formed a single synaptic connection(eciipn-ca1pv synapses) with the inhibitory small abruption protein cells of the hippocampus CA1 region (CA1PV) (Shu et al., 2016; Yang et al., 2018) . In the transgenic mouse model of Alzheimer's disease, this memory loop is selectively damaged (Yang et al., 2018) . Researchers used optogenetics stimulation therapy to repair eciipn-ca1pv synaptic degeneration damage and effectively treat memory loss in Alzheimer's disease (Table 1 and Figure 2 ). This experiment proves that this loop is involved in regulating spatial learning and memory (Yang et al., 2018) . In another study, researchers combined optogenetic technology with multichannel synchronous optical stimulation and electrical recording technology, and found a circuit of emotional influence on spatial learning and memory in terms of structure and function . Vahaba et al. (2017) used optogenetics to manipulate the NIF and HVC regions in the brains of zebra finches (Spierings and ten Cate, 2014) . By controlling the interaction of these two regions, the researchers managed to encode the finches' memories (Vahaba et al., 2017) . Huang et al. (2021) (Table 1 and Figure 2) , Huang et al. treated mice with phototherapy and recorded the potential changes in the hippocampal CA1 region of mice. The results showed that light therapy improved spatial memory and was associated with changes in the activity patterns of hippocampal neurons. These studies on spatial learning and memory could provide insights into the treatment of Alzheimer's disease and some psychiatric disorders. Drug addiction (Martinez-Gonzalez et al., Xu et al., 2021) is an abnormal learning and memory process. Withdrawal scenarios can reactivate the addictive memory when the patient enters a scene that was previously associated with withdrawal symptoms (Hellemans et al., 2006) . According to previous studies, the basolateral amygdala (BLA) plays an important role in inducing addictive memory retrieval (Wang et al., 2014; Khakpoor et al., 2016; Yi et al., 2021) . However, its downstream neural circuits remain unknown. In this study, researchers combined neural tracer, optogenetics, chemical genetics and other methods. It was found that after activation of BLA -PrL loop, PrL was induced to transmit information back to BLA by projecting neurons, so as to activate the increase of Arc protein expression level in another group of BLA neurons and cause the recall of addictive memory (Table 1 and Figure 2 ; Alaghband et al., 2014) . The study revealed the important role of the prefrontal cortex as a hub of the neural circuits in reactivating addictive memories in withdrawal scenarios, providing support for the treatment of drug addiction. Alzheimer's Disease Currently, none of the drugs used to improve cognitive function can fundamentally treat Alzheimer's disease, but can only alleviate the symptoms. In 2016, Roy's team successfully restored memory in mice using optogenetics (Table 1 and Figure 3 ; Roy et al., 2016) . In the study, the researchers implanted lightsensitive proteins into the hippocampus of mice with memory loss. In response to light, memory cells in the hippocampus of the mice were activated. The next day, without light, the mice lost their memory again. As shown in the study, the hippocampus of the memory recovery mice established a strong connection with the entorhinal cortex (Meda et al., 2013) which is missing in Alzheimer's patients (Liu and Zhang, 2019; Vallee et al., 2020) . Another study used optogenetics stimulation therapy to repair eciipn-ca1pv synaptic degeneration damage and effectively treat memory damage caused by Alzheimer's disease (Figure 3 ; Yang et al., 2018) . At the same time, an important research achievement in Alzheimer's disease is the treatment of cognitive dysfunction with near-infrared bioluminescence (Saltmarche et al., 2017; Arenas et al., 2020) . Up to now, many studies have demonstrated that near-infrared bioluminescence therapy can improve cognitive function (Chao, 2019; Kinouchi et al., 2021) . The above research may provide ideas for the radical cure of Alzheimer's disease. Parkinson's disease is a chronic disease with no clinical cure (Guo et al., 2019; Altinoz et al., 2020) . However, Parkinson's disease can be alleviated and treated with optogenetics. Ztaou et al. (2016) found that bilateral activation of indirect pathway MSNs by optogenetics can produce Parkinson's-like presentation. However, activation of MSNs in the direct pathway alleviates symptoms such as freezing, bradykinesia, and difficulty in initiating movement (Kravitz et al., 2010; de Almeida and da Silva, 2021; Malaquias et al., 2021; Yang X. et al., 2021) . Yang et al. (2018) found that the use of optogenetics combined with deep brain stimulation (DBS) (Castano-Candamil et al., 2019) to stimulate the afferent axons of the subthalamic nucleus region at high frequency can significantly treat Parkinson's disease (Table 1 and Figure 3) . Carter et al. (2010) used optogenetic targeting to control the LC-NE region of the cerebral cortex of mice, and were able to treat sleep disorders in mice with Parkinson's disease (Figure 3) . Steinbeck et al. (2015) induced rapid and reversible reactivation of motor defects in mice that had recovered from Parkinson's motor defects induced by injury (Figure 3) . And a recent study showed that photogenetic stimulation of the deep brain can relieve Parkinson's disease in rats (Ingram et al., 2020; Yu et al., 2020) . These studies suggest that optogenetics has great potential in the clinical treatment of Parkinson's disease. More than 20% of epileptic patients develop stubborn resistance to epileptic drugs (Zhou et al., 2013; Murawiec et al., 2020) , which eventually develops into refractory epilepsy (Martinez-Juarez et al., 2012; Tsai et al., 2021) . The researchers injected green light-emitting nanoparticles into the hippocampus of mice (Roet et al., 2019) , and irradiated the cranium surface with infrared light, and found that the epileptic neurons of mice were effectively silenced (Table 1 and Figure 3 ; Chen et al., 2018) . The nanoparticles used in this experiment are stable, biocompatible and can be used for a long time. Lu et al. (2016) conducted in vivo and in vitro experiments, and the excitatory photosensitive protein was expressed in inhibitory neurons to inhibit epileptoid activity up to 70.0 and 82.4%, respectively. These studies indicate that optogenetic techniques are superior to other methods in the treatment of epilepsy. Cerebral apoplexy (Ng et al., 2019) is caused by the obstruction of blood flow to the brain tissues caused by vascular obstruction, which often occurs suddenly, with such symptoms as fainting, hemiplegia, and slant of the tongue, with a high mortality and disability rate. There is still a lack of effective treatment drugs, and transplantation of nerve progenitor cells is a good way to restore the function of nerve neurons in the brain (Cabral-Costa and Kowaltowski, 2020; Ostolaza et al., 2020; Roy-O'Reilly et al., 2020) . Yu et al. (2019) provided luciferin CTZ to the brain of mice by intranasal administration (Table 1) . When CTZ encounters luminescent proteins, it emits the required light. This study showed that survival rates for the growth and differentiation of neural progenitor cells increased significantly, more intact axons and nerve connections were produced, and better responses to electrical stimulation were achieved. The affected limb also showed better recovery. In young mice, stroke affected limb function was restored to normal levels, and even in older mice, stroke symptoms were partially recovered (Table 1 and Figure 3) . The findings offer hope for an effective treatment for stroke. A memory can bring either pleasure or fear (Kirmayer et al., 1995; Riksen and Netea, 2020) . And relevant neurobiological studies have shown that an experience can cause changes in multiple brain areas, such as the cerebral cortex, hippocampus and amygdala, thus producing memory (Josselyn et al., 2015) . In the following studies, optogenetics can manipulate memories and erase bad memories by manipulating neurons in the brain. In 2014, researchers successfully removed and reactivated a certain memory by changing the connections of related neurons in the brain of rats with different frequencies of light (Table 1 and Figure 3 ; Nabavi et al., 2014) . In 2017, researchers used optogenetic technology in conjunction with electrophysiological technology and behavioral experiments (Ishikawa and Sakaguchi, 2013) to study the role of specific neural pathways in fear memory (Klavir et al., 2017; Yilmaz et al., 2020) . In 2019, relevant studies for the first time found the subgroup of neurons that regulate the new memory of fear extinction, which improved people's cognition of fear memory (Lacagnina et al., 2019) . Also, in 2019, people used optogenetic methods to manipulate memory-related neurons to encode memory imprinting without experience for the first time (Table 1 and Figure 3 ; Vetere et al., 2019) . The above research indicates that optogenetics plays an important role in the study of the mechanism of memory generation and memory-related diseases. In the past, electric stimulation was often used for patients who lost motor function, and the electric stimulation treatment was prone to muscle fatigue and inaccurate discharge (Asakawa et al., 2021) . However, optogenetics can stimulate a certain muscle fiber accurately and with low trauma, which can be used to study the treatment of motor system injury. In 2010, researchers started to apply optogenetics to the treatment of motor impairment (Table 1 and Figure 3) . Llewellyn et al. (2010) utilized light stimulation of muscle fibers, and after 20 min of light stimulation of muscle fibers, the muscle still maintained a third of the maximum stress (Table 1 and Figure 3) . Bryson et al. (2014) constructed a mouse model of muscle loss innervation and transplanted the embryoid containing ChR2 motor neurons into the mouse. By shining blue light on the transplant site, the researchers were able to restore leg muscle function (Table 1 and Figure 3) . Srinivasan et al. (2018) used tiny LED lights to control light-sensitive proteins expressed in the legs of mice. The study succeeded in controlling ankle movement in mice. These studies suggest that optogenetics has great potential in controlling biological motor systems, especially in the treatment of paralysis and the treatment of muscle degeneration. Related researchers developed a full closed-loop optogenetic control system (Mickle et al., 2019) and implanted it into female mice with drug-induced bladder dysfunction. This system can detect bladder filling, and the system can also irradiate the bladder for optogenetic control (Kessler et al., 2019) . Shown in the study, photosensitive proteins are expressed in nerve cells of the bladder in mice by optogenetics technique, which makes the neurons in the bladder of mice in a hyperpolarized state. For 7 days after the system was implanted, the mice did well. Finally, the rats returned to normal bladder function (Table 1 and Figure 3 ; Mickle et al., 2019) . Through further research and testing, this method is of clinical value. Pain is one of the common clinical symptoms. Prolonged severe pain can seriously affect the patient's quality of life. At present, photogenetic technology can solve the pain problem very well. In 2017, a new in-spinal optogenetics device was used for pain treatment and research (Table 1 and Figure 3 ; Samineni et al., 2017; Mai et al., 2020) . Using this device, the researchers activated the afferent nerve of trpv1-chr2 channel protein, causing pain response behavior in mice (Jacob and Szerb, 1951; Zhu et al., 2020; Ji et al., 2021; . The researchers then ran a real-time comparison experiment, and the results were the same. Now that the device's function is clear, it can be widely used in pain research. Another study used the selective silencing of related neurons by a wirelessly controlled electro-optical system to reduce ongoing pain and induced skin allergic reactions in mice under cystitis conditions (Table 1 and Figure 3 ; Samineni et al., 2017) . And it had no bad effect on the mice. Hua et al. (2020) discovered a class of inhibitory neurons called "CeAga." It turns off pain. Inhibition of the expression of CeAga neurons by optogenetics stopped the pain behavior in mice . Due to its high accuracy and low side effects, optogenetics may be widely used in the field of pain in the near future. Special neurons in the retina react to light and transmit it to the brain to produce vision (Pozarickij et al., 2020; Creeden et al., 2021; Liu H. et al., 2021; Yu et al., 2021; Elkhalifa et al., 2022) . When neurons in the retina stop working properly, the eye can't work properly. Nowadays, optogenetic can be used to treat eye diseases such as color blindness (Table 1 and Figure 3 ; Cideciyan et al., 2016) . The researchers sensitized the cells to light by the expression of light genes that encode light-activated channels or pumps in the remaining retinal cells (Ostrovsky and Kirpichnikov, 2019; Blomeier et al., 2021; He et al., 2021; Kramer et al., 2021; Mickoleit et al., 2021) . Relevant research has achieved good results in recent years. In 2017, Russian scientists injected drugs with certain genetic structure into the blind eyes of experimental rodents, and the sight of experimental animals was partially restored (Aung et al., 2017) . Berry et al. (2019) restored vision to blind mice (Table 1 and Figure 3 ). In 2021, the company of Bionic Sight successfully used optogenetics to enable patients with advanced retinitis pigmentosa to see light and motion (Harris and Gilbert, 2022) . Since the advent of optogenetics, the technology has occupied the research field of neurobiology. Using optogenetics, researchers have decoded many neural circuits that cannot be decoded with other techniques. Such as social behavioral neural circuits, body temperature regulating neural circuits, spatial learning and memory circuits and so on. In view of the minimally invasive and high accuracy of optogenetics, optogenetics has a broad prospect in clinical treatment. Many irreversible diseases, especially neurodegenerative changes, can be solved by optogenetics. And the related research has entered the clinical trial stage. Although optogenetics has achieved a lot in many fields, it still faces many challenges. Many scientists have proposed that exogenous light exposure causes neurons to respond in a nonphysiological way, leading to incorrect physiological conclusions (Oh et al., 2021) . And whether exogenous photosensitive proteins can have potential effects on nerve cells. Due to economic and other factors, optogenetics is mostly used in mouse experiments. Clinical trials of optogenetics are rare. Therefore, it will take a long time to prove that optogenetics can be widely applied to humans. At present, optogenetics continues to flourish. Photogenetic treatments for retinal degeneration (Cehajic-Kapetanovic et al., 2019; Gilhooley et al., 2021) and pain (Harriott et al., 2021) are also in clinical trials. Researchers are also developing more precise (Adesnik and Abdeladim, 2021) and less invasive optogenetic devices, such as SOUL (Gong et al., 2020) . At the same time, optogenetics has strong compatibility, it can be used to study a variety of diseases, such as diabetes , inflammation (Baumschlager and Khammash, 2021; Bhat et al., 2021; Dos Santos et al., 2021; Jamaluddin et al., 2021; Michoud et al., 2021; Santos et al., 2021; Senok et al., 2021) , tumors (Kim et al., 2017; Adampourezare et al., 2021; Esmaeili et al., 2022) , depression (Hare et al., 2019) , epilepsy (Zhang and Wang, 2021) and so on. And in 2020, 45 laboratories around the world integrated all optogenetics resources and create an optogenetics experimental database (Tremblay et al., 2020) . According to the current progress, optogenetics has a broad prospect. It is believed that soon, optogenetics will become a major technique in neurobiology. Optogenetics: 10 years after ChR2 in neurons-views from the community Application of lateral flow and microfluidic bio-assay and biosensing towards identification of DNA-methylation and cancer detection: recent progress and challenges in biomedicine Probing neural codes with two-photon holographic optogenetics Retrieval-induced NMDA receptor-dependent arc expression in two models of cocaine-cue memory PPARdelta and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease Optical control of CD8(+) T cell metabolism and effector functions Behavioral flexibility is increased by optogenetic inhibition of neurons in the nucleus accumbens shell during specific time segments STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and down syndrome Illuminating ALS motor neurons with optogenetics in zebrafish Deconstruction of a neural circuit for hunger Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci Synthetic biological approaches for optogenetics and tools for transcriptional light-control in bacteria Restoration of high-sensitivity and adapting vision with a cone opsin AFM-based correlative microscopy illuminates human pathogens Blue light-operated CRISPR/Cas13b-mediated mRNA knockdown (lockdown) Millisecond-timescale, genetically targeted optical control of neural activity Type II diabetes and oral health: perceptions among adults with diabetes and oral/health care providers in Ghana Marking multichannel silicon-substrate electrode recording sites using radiofrequency lesions Optical control of muscle function by transplantation of stem cell-derived motor neurons in mice The preference for sugar over sweetener depends on a gut sensor cell Neurological disorders and mitochondria Social difficulties as risk and maintaining factors in anorexia nervosa: a mixed-method investigation. Front Driving fast-spiking cells induces gamma rhythm and controls sensory responses Tuning arousal with optogenetic modulation of locus coeruleus neurons An easy-to-use and fast assessment of patient-specific DBS-induced changes in hand motor control in Parkinson's disease Clinical and molecular characterization of PROM1-related retinal degeneration Effects of home photobiomodulation treatments on cognitive and behavioral function, cerebral perfusion, and resting-state functional connectivity in patients with dementia: a pilot trial Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics Developing an outcome measure with high luminance for optogenetics treatment of severe retinal degenerations and for gene therapy of cone diseases Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning -a preliminary observations Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection Hydra hymanae: regulation of the life cycle by time and temperature Does polysaccharide quaternization improve biological activity? The rise of molecular optogenetics A new target organ of leishmania (viannia) braziliensis chronic infection: the intestine Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases Mesoporous silica@chitosan@gold nanoparticles as "on/off " optical biosensor and pH-sensitive theranostic platform against cancer The role of microglia in perioperative neurocognitive disorders Mesenchymal stem cells: ideal seeds for treating diseases Brilliant glycans and glycosylation: seq and ye shall find Locomotion control: brainstem circuits satisfy the need for speed Central regulation of sodium appetite ON-bipolar cell gene expression during retinal degeneration: implications for optogenetic visual restoration CRISPR/dCas9 switch systems for temporal transcriptional control An ultra-sensitive step-function opsin for minimally invasive optogenetic stimulation in mice and macaques Investigation of the roles of dysbindin-1 and SATB2 in the progression of Parkinson's disease Correlating in vitro and in vivo activities of light-inducible dimers: a cellular optogenetics guide Hypothalamus, temperature regulation, and feeding in the rat Integrated control of predatory hunting by the central nucleus of the amygdala Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects Optogenetic spreading depression elicits trigeminal pain and anxiety behavior Restoring vision using optogenetics without being blind to the risks Design of smart antibody mimetics with photosensitive switches Disrupting reconsolidation of conditioned withdrawal memories in the basolateral amygdala reduces suppression of heroin seeking in rats Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cellpenetrating peptides involved in pathogenesis or applicable as drug delivery vectors Chemical tools with fluorescence switches for verifying epigenetic modifications Trends of obesity in 10-years of follow-up among tehranian children and adolescents: tehran lipid and glucose study (TLGS) Optogenetic manipulation of selective neural activity in free-moving drosophila adults General anesthetics activate a potent central pain-suppression circuit in the amygdala A visual circuit related to the nucleus reuniens for the spatial-memory-promoting effects of light treatment Sex specific inflammatory profiles of cerebellar mitochondria are attenuated in Parkinson's disease Both movement-end and task-end are critical for error feedback in visuomotor adaptation: a behavioral experiment G-quadruplex microspheres-based optical RNA biosensor for arthropod-borne virus pathogen detection: a proof-of-concept with dengue serotype 2 Visualizing hypothalamic network dynamics for appetitive and consummatory behaviors IL-23 enhances C-fiber-mediated and blue light-induced spontaneous pain in female mice Finding the engram Gereau RWt: impaired inflammatory pain and thermal hyperalgesia in mice expressing neuron-specific dominant negative mitogen activated protein kinase kinase (MEK) Neuromodulation of urinary tract function Additive effect of BLA GABAA receptor mechanism and (+)-MK-801 on memory retention deficit, an isobologram analysis Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment Organ-specific, multimodal, wireless optoelectronics for highthroughput phenotyping of peripheral neural pathways Circadian rhythms in the tissue-specificity from metabolism to immunity: insights from omics studies The cultural context of anxiety disorders Manipulating fear associations via optogenetic modulation of amygdala inputs to prefrontal cortex Multichromatic control of signaling pathways in mammalian cells Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry Distinct hippocampal engrams control extinction and relapse of fear memory Scalable control of mounting and attack by Esr1+ neurons in the ventromedial hypothalamus Chemosensory modulation of neural circuits for sodium appetite A synthetic BRETbased optogenetic device for pulsatile transgene expression enabling glucose homeostasis in mice MicroRNA-132 promotes neurons cell apoptosis and activates tau phosphorylation by targeting GTDC-1 in Alzheimer's disease Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway How wide is the application of genetic big data in biomedicine Orderly recruitment of motor units under optical control in vivo Gut microecology: why our microbes could be key to our health Nanomedicines: redefining traditional medicine Optogenetic dissection of ictal propagation in the hippocampal-entorhinal cortex structures Optogenetic modulation and reprogramming of bacteriorhodopsin-transfected human fibroblasts on self-assembled fullerene C60 nanosheets p38 mitogenactivated protein kinase and pain A review of plant-based expression systems as a platform for single-domain recombinant antibody production Self-deception as a mechanism for the maintenance of drug addiction Alzheimer's disease neuroimaging i: genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's disease neuroimaging initiative A simple optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally-encoded inputs Method of the year Epineural optogenetic activation of nociceptors initiates and amplifies inflammation A wireless closed-loop system for optogenetic peripheral neuromodulation High-yield production, characterization, and functionalization of recombinant magnetosomes in the synthetic bacterium rhodospirillum rubrum "magneticum The plastic cell: mechanical deformation of cells and tissues optoPAD, a closed-loop optogenetics system to study the circuit basis of feeding behaviors Increasing the dosage of pregabalin in patients with focal epilepsy decreases the frequency of seizures and ameliorates symptoms of anxiety, depression and insomnia Engineering a memory with LTD and LTP Insights of the decade. stepping away from the trees for a look at the forest. introduction Consensus-based statements for the management of mitochondrial stroke-like episodes Decoding neural circuits that control compulsive sucrose seeking Optogeneticsshining light on neurosurgical conditions Steering molecular activity with optogenetics: recent advances and perspectives Circular RNA expression profile in blood according to ischemic stroke etiology Prospects of optogenetic prosthesis of the degenerative retina of the eye B12-based photoreceptors: from structure and function to applications in optogenetics and synthetic biology The Impact of Aging on Macroautophagy in the Pre-ovulatory Mouse Oocyte and the UKBE, vision C: non-additive (dominance) effects of genetic variants associated with refractive error and myopia Chronically implantable LED arrays for behavioral optogenetics in primates Immunometabolic control of trained immunity Progress in neuromodulation of the brain: a role for magnetic nanoparticles? Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease Aging exacerbates neutrophil pathogenicity in ischemic stroke Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report Optogenetic silencing of nociceptive primary afferents reduces evoked and ongoing bladder pain Oral delivery of fish oil in oil-in-water nanoemulsion: development, colloidal stability and modulatory effect on in vivo inflammatory induction in mice Lateral flow immunoassay for the detection of panton-valentine leukocidin in staphylococcus aureus from skin and soft tissue infections in the united arab emirates Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation Selective degeneration of entorhinal-CA1 synapses in Alzheimer's disease via activation of DAPK1 Big data-driven precision medicine: starting the custom-made era of iatrology Zebra finches are sensitive to prosodic features of human speech Thalamic projections to the primary and secondary somatosensory cortices in cat: single and double retrograde tracer studies Closed-loop functional optogenetic stimulation Optogenetics enables functional analysis of human embryonic stem cellderived grafts in a Parkinson's disease model Agouti-related protein neuron circuits that regulate appetite The effects of centrally administered porcine relaxin on drinking behaviour in male and female rats An open resource for non-human primate optogenetics Calcium-dependent signal transduction pathways in plantsphytochrome mechanism of action as an example Late-onset epilepsy and subsequent increased risk of dementia Sensory coding and sensitivity to local estrogens shift during critical period milestones in the auditory cortex of male songbirds Optogenetic and transcriptomic interrogation of enhanced muscle function in the paralyzed mouse whisker pad Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/beta-catenin pathway Onecut regulates core components of the molecular machinery for neurotransmission in photoreceptor differentiation Memory formation in the absence of experience Multiple factors in the satiation of salt appetite Optogenetic control of selective neural activity in multiple freely moving drosophila adults The role of the inflammasomes in the pathogenesis of uveitis Photo-crosslinked GelMA/collagen membrane loaded with lysozyme as an antibacterial corneal implant A novel mechanism of memory loss in Alzheimer's disease mice via the degeneration of entorhinal-CA1 synapses Wireless multilateral devices for optogenetic studies of individual and social behaviors Optogenetics: a novel optical manipulation tool for medical investigation Comparative proteomic analysis identifies biomarkers for renal aging A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation Pharmacomolecular assessment of the effects of anandamide and its antagonists on hippocampal tissue in Wistar albino rats Frequencyspecific optogenetic deep brain stimulation of subthalamic nucleus improves parkinsonian motor behaviors Qingfei oral liquid inhibited autophagy to alleviate inflammation via mTOR signaling pathway in RSV-infected asthmatic mice Optochemogenetic stimulation of transplanted iPS-NPCs enhances neuronal repair and functional recovery after ischemic stroke iBLP: an xgboost-based predictor for identifying bioluminescent proteins Gene therapy in epilepsy CRISPR technology: the engine that drives cancer therapy Activation of the dopaminergic pathway from VTA to the medial olfactory tubercle generates odor-preference and reward A hypothalamic circuit that controls body temperature An integrating immunerelated signature to improve prognosis of hepatocellular carcinoma Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease XZ and ZL designed this study and supervised the research. WC wrote the manuscript. WL, YLi, ZZ, YX, YLiao, LY, QL, and MH discussed the manuscript. CL, ZL, and XZ edited the manuscript. All authors read and approved the final manuscript. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.